AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$22.77
-0.16 (-0.70%)
▼
5d:
-10.39%
30d:
-38.02%
90d:
-37.79%
WAIT
LOW Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 07, 2026
0d
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AORT is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AORT is down 10.4% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$39.27
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$24.39
6.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $22.77, which is considered oversold relative to its 30-day fair value range of $32.19 to $38.90. From a valuation perspective, the stock is trading at a discount (Forward PE: 28.2) compared to its historical average (40.4). Remarkably, the market is currently pricing in an annual earnings decline of 11.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $19.16, while resistance sits at $36.47.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.88 (+88.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $19.16, while resistance sits at $36.47.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $42.88 (+88.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$32.19 -
$38.90
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
Protect Your Profits
Holding AORT? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 88.3% below Wall St target ($42.88)
- WARNING: Recommendation downgraded due to -10.4% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$32.19 -
$38.90
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$19.16
Resistance Level
$36.47
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
28.23
Wall Street Target
$42.88
(+88.3%)
Revenue Growth (YoY)
17.5%
Profit Margin
2.5%
Valuation Discount vs History
-11.3% cheaper
PE vs Historical
28.2 vs 40.4
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-11.3%
(market-implied from PE analysis)
1-Year Target
$20.49
(-10%)
2-Year Target
$18.44
(-19%)
3-Year Target
$16.60
(-27%)
3-Yr Target (if PE normalizes)
(PE: 28→40)
$23.76
(+4%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.2, Growth: 56.1%)
$76.85
(+238%)
Base:
(SPY PE: 22.1, Growth: 56.1%)
$60.09
(+164%)
Bear:
(PE: 18.8, Growth: 56.1%)
$51.07
(+124%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (41x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Forward PE: 41.32 | Forward EPS (Implied): $0.55
Bull Case
$27.49
(+21%)
Analyst growth 15.0%, PE expands to 43.4
Base Case
$22.77
(0%)
Market implied 0.0%, PE stable at 41.3
Bear Case
$17.42
(-24%)
Severe decline -15.0%, PE contracts to 37.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.2 to 40.4
Stabilization Target:
$32.59
(+43.1%)
PE Expansion Potential:
+43.1%
Share & Embed Analysis
Last updated: May 18, 2026 3:18 AM ET
Data refreshes hourly during market hours. Next update: 4:18 AM
Data refreshes hourly during market hours. Next update: 4:18 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$83 | 66 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$389 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 64 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$250 | 59 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 55 HOLD |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
